Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.

Magro F, Lopes J, Borralho P, Lopes S, Coelho R, Cotter J, Dias de Castro F, Tavares de Sousa H, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Chagas C, Cravo M, Dias CC, Afonso J, Portela F, Santiago M, Geboes K, Carneiro F.

J Crohns Colitis. 2019 Sep 4. pii: jjz123. doi: 10.1093/ecco-jcc/jjz123. [Epub ahead of print]

PMID:
31504348
2.

Comparison of different histological indexes in the assessment of UC activity and their accuracy regarding endoscopic outcomes and faecal calprotectin levels.

Magro F, Lopes J, Borralho P, Lopes S, Coelho R, Cotter J, Castro FD, Sousa HT, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Rosa I, Rodrigues M, Chagas C, Dias CC, Afonso J, Geboes K, Carneiro F; Portuguese IBD Study Group (GEDII).

Gut. 2019 Apr;68(4):594-603. doi: 10.1136/gutjnl-2017-315545. Epub 2018 Feb 3.

PMID:
29437913
3.

Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.

Zittan E, Kelly OB, Kirsch R, Milgrom R, Burns J, Nguyen GC, Croitoru K, Van Assche G, Silverberg MS, Steinhart AH.

Inflamm Bowel Dis. 2016 Mar;22(3):623-30. doi: 10.1097/MIB.0000000000000652.

PMID:
26829408
4.

Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.

Hart L, Chavannes M, Kherad O, Maedler C, Mourad N, Marcus V, Afif W, Bitton A, Lakatos PL, Brassard P, Bessissow T.

J Crohns Colitis. 2019 Jun 10. pii: jjz107. doi: 10.1093/ecco-jcc/jjz107. [Epub ahead of print]

PMID:
31314884
5.

Development and validation of a histological index for UC.

Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, Shackelton LM, Walker CW, Nelson S, Vandervoort MK, Frisbie V, Samaan MA, Jairath V, Driman DK, Geboes K, Valasek MA, Pai RK, Lauwers GY, Riddell R, Stitt LW, Levesque BG.

Gut. 2017 Jan;66(1):50-58. doi: 10.1136/gutjnl-2015-310393. Epub 2015 Oct 16.

PMID:
26475633
6.

Accuracy of Faecal Calprotectin and Neutrophil Gelatinase B-associated Lipocalin in Evaluating Subclinical Inflammation in UlceRaTIVE Colitis-the ACERTIVE study.

Magro F, Lopes S, Coelho R, Cotter J, Dias de Castro F, Tavares de Sousa H, Salgado M, Andrade P, Vieira AI, Figueiredo P, Caldeira P, Sousa A, Duarte MA, Ávila F, Silva J, Moleiro J, Mendes S, Giestas S, Ministro P, Sousa P, Gonçalves R, Gonçalves B, Oliveira A, Chagas C, Torres J, Dias CC, Lopes J, Borralho P, Afonso J, Geboes K, Carneiro F; Portuguese IBD Study Group [GEDII].

J Crohns Colitis. 2017 Apr 1;11(4):435-444. doi: 10.1093/ecco-jcc/jjw170.

PMID:
27664275
7.

Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study.

Lobatón T, Bessissow T, Ruiz-Cerulla A, De Hertogh G, Bisschops R, Guardiola J, Van Assche G, Vermeire S, Ferrante M.

United European Gastroenterol J. 2018 Jun;6(5):765-772. doi: 10.1177/2050640617752207. Epub 2018 Jan 8.

8.

The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.

Carlsen K, Riis LB, Elsberg H, Maagaard L, Thorkilgaard T, Sørbye SW, Jakobsen C, Wewer V, Florholmen J, Goll R, Munkholm P.

Scand J Gastroenterol. 2018 Jun - Jul;53(7):825-830. doi: 10.1080/00365521.2018.1482956. Epub 2018 Jul 3.

PMID:
29968483
9.

Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.

Walsh A, Kormilitzin A, Hinds C, Sexton V, Brain O, Keshav S, Uhlig H, Geddes J, Goodwin G, Peters M, Collins G, Travis S.

J Crohns Colitis. 2019 Mar 30;13(4):424-430. doi: 10.1093/ecco-jcc/jjy184.

PMID:
30445625
10.

Histological Outcomes and Predictive Value of Faecal Markers in Moderately to Severely Active Ulcerative Colitis Patients Receiving Infliximab.

Magro F, Lopes SI, Lopes J, Portela F, Cotter J, Lopes S, Moreira MJ, Lago P, Peixe P, Albuquerque A, Rodrigues S, Silva MR, Monteiro P, Lopes C, Monteiro L, Macedo G, Veloso L, Camila C, Afonso J, Geboes K, Carneiro F; Portuguese IBD group [GEDII].

J Crohns Colitis. 2016 Dec;10(12):1407-1416. Epub 2016 May 25.

PMID:
27226417
11.

The Modified Mayo Endoscopic Score (MMES): A New Index for the Assessment of Extension and Severity of Endoscopic Activity in Ulcerative Colitis Patients.

Lobatón T, Bessissow T, De Hertogh G, Lemmens B, Maedler C, Van Assche G, Vermeire S, Bisschops R, Rutgeerts P, Bitton A, Afif W, Marcus V, Ferrante M.

J Crohns Colitis. 2015 Oct;9(10):846-52. doi: 10.1093/ecco-jcc/jjv111. Epub 2015 Jun 26.

PMID:
26116558
12.

Accuracy of Faecal Immunochemical Test to Predict Endoscopic and Histological Healing in Ulcerative Colitis: A Prospective Study Based on Validated Histological Scores.

Shi HY, Chan FKL, Chan AWH, Higashimori A, Kyaw M, Ching JYL, Luk AKC, Wong SH, Wu JCY, Sung JJY, Ng SC.

J Crohns Colitis. 2017 Sep 1;11(9):1071-1077. doi: 10.1093/ecco-jcc/jjx088.

PMID:
28881876
13.

Correlation Between Endoscopic and Histological Activity in Ulcerative Colitis Using Validated Indices.

Irani NR, Wang LM, Collins GS, Keshav S, Travis SPL.

J Crohns Colitis. 2018 Nov 9;12(10):1151-1157. doi: 10.1093/ecco-jcc/jjy081.

PMID:
29893824
14.

Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.

Patel A, Panchal H, Dubinsky MC.

Inflamm Bowel Dis. 2017 Sep;23(9):1600-1604. doi: 10.1097/MIB.0000000000001157.

PMID:
28590341
15.

Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin.

Karling P, Lundgren D, Eklöf V, Palmqvist R, Hultdin J.

Scand J Clin Lab Invest. 2019 Sep;79(5):341-346. doi: 10.1080/00365513.2019.1622148. Epub 2019 Jun 4.

PMID:
31164011
16.

Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.

Fluxá D, Simian D, Flores L, Ibáñez P, Lubascher J, Figueroa C, Kronberg U, Pizarro G, Castro M, Piottante A, Vial MT, Quera R.

J Dig Dis. 2017 Nov;18(11):634-641. doi: 10.1111/1751-2980.12546.

PMID:
28949435
17.

Histological healing after infliximab induction therapy in children with ulcerative colitis.

Wiernicka A, Szymanska S, Cielecka-Kuszyk J, Dadalski M, Kierkus J.

World J Gastroenterol. 2015 Oct 7;21(37):10654-61. doi: 10.3748/wjg.v21.i37.10654.

18.

Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis.

Mak WY, Buisson A, Andersen MJ Jr, Lei D, Pekow J, Cohen RD, Kahn SA, Pereira B, Rubin DT.

Dig Dis Sci. 2018 May;63(5):1294-1301. doi: 10.1007/s10620-018-4980-0. Epub 2018 Feb 22.

PMID:
29468374
20.

Responsiveness of histological disease activity indices in ulcerative colitis: a post hoc analysis using data from the TOUCHSTONE randomised controlled trial.

Jairath V, Peyrin-Biroulet L, Zou G, Mosli M, Vande Casteele N, Pai RK, Valasek MA, Marchal-Bressenot A, Stitt LW, Shackelton LM, Khanna R, D'Haens GR, Sandborn WJ, Olson A, Feagan BG, Pai RK.

Gut. 2019 Jul;68(7):1162-1168. doi: 10.1136/gutjnl-2018-316702. Epub 2018 Aug 3.

PMID:
30076171

Supplemental Content

Support Center